Li, Ning

Metabolic modulation of tumours with engineered bacteria for immunotherapy

Canale, F. P., Basso, C., Antonini, G., Perotti, M., Li, N., Sokolovska, A., Neumann, J., James, M. J., Geiger, S., Jin, W., et al. (2021) · Nature

Bacterial Cancer TherapyCancer Immunotherapy and Biomarkers

Cited by 619

Development of a synthetic live bacterial therapeutic for the human metabolic disease phenylketonuria

Isabella, V. M., Ha, B. N., Castillo, M. J., Lubkowicz, D. J., Rowe, S. E., Millet, Y. A., Anderson, C. L., Li, N., Fisher, A. B., West, K. A., et al. (2018) · Nature Biotechnology

Bacterial Cancer TherapyProbiotics and Fermented Foods

Cited by 605

Developing a new class of engineered live bacterial therapeutics to treat human diseases

Charbonneau, M. R., Isabella, V. M., Li, N., & Kurtz, C. B. (2020) · Nature Communications

Bacterial Cancer TherapyProbiotics and Fermented Foods

Cited by 523

Immunotherapy with engineered bacteria by targeting the STING pathway for anti-tumor immunity

Leventhal, D. S., Sokolovska, A., Li, N., Plescia, C., Kolodziej, S. A., Gallant, C. W., Christmas, R., Gao, J.-R., James, M. J., Abin-Fuentes, A., et al. (2020) · Nature Communications

Bacterial Cancer TherapyImmunotherapy and Immune Responses

Cited by 458